Understanding how people access and use naloxone for overdose prevention
A National Survey on Naloxone Use and Access
This study is looking at how easy it is for people to get and use naloxone, a lifesaving medicine that can reverse opioid overdoses, by asking questions about who carries it, where they get it, and any challenges they face, so we can help make it more available and affordable for everyone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-10923463 on NIH RePORTER |
What this research studies
This research investigates the accessibility and usage of naloxone, a medication used to reverse opioid overdoses, among the general public. It aims to identify how many people carry naloxone, where they obtain it, and the barriers they face in accessing it. The study will involve surveys and vignettes to gather data on purchasing behaviors and optimal pricing for naloxone, especially as new over-the-counter options become available. By monitoring these factors, the research seeks to provide insights that can inform policies to improve naloxone distribution and affordability.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at risk of opioid overdose or those who know someone at risk, as well as healthcare providers involved in naloxone distribution.
Not a fit: Patients who do not use or are not at risk of opioid medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to naloxone, potentially saving lives by reducing overdose deaths.
How similar studies have performed: Previous research has shown that improving naloxone access among laypersons can effectively reduce overdose deaths, indicating that this approach has potential for success.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Powell, David — Rand Corporation
- Study coordinator: Powell, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.